Life-Saving Ventilators Are In Short Supply Worldwide

Life-saving ventilators are in short supply worldwide!

2022 Ventilators For some patients with neo-coronary critical illness, mechanically assisted ventilation is the treatment that determines whether they can recover or die.

Throw away about 10% of critically ill patients, combined with the first-line treatment, at least 1/3 of the remaining patients to ventilator-assisted oxygenation. The need for ventilators has exceeded 100,000 units in the short term because it cannot share them.

There is a global shortage of ventilators! Shortage! There is a shortage!

"Every state in the U.S. is buying ventilators, and there is a shortage of domestic inventory, so we have to send people to China, the largest manufacturer of ventilators, to buy them." New York Governor Andrew Cuomo said. "New York alone may need 30,000 ventilators, but the state currently has only 6,000."

According to the New York Times, Andreas Wieland, chief executive of the medical company Hamilton Medical based in Switzerland, said, "The reality is that there is not enough equipment." The company is also one of the world's largest manufacturers of ventilators.

As you can see, it is not just New York State facing a shortage of ventilators, but the entire United States. It is known that there are currently about 160,000 ventilators in hospitals in the U.S. In addition, there are 12,700 ventilators in the U.S. in the National Strategic Stockpile, a medical supply reserved by the U.S. federal government to respond to national emergencies. As the epidemic continues to grow, this number may be far from enough, and it is only a matter of time before a shortage occurs.

Some industry speculation, the epidemic continues to develop, mainly in Asia and Europe, several countries have long swept up the global supply of ventilators, and the existing capacity in a state of oversupply, it is challenging to meet the new demand from the United States.

Almost at the same time, British Prime Minister Johnson asked more than 60 domestic manufacturers to replace their equipment and transform the production of specialized medical equipment, including respirators.

Italy, where the epidemic is most profound, has also asked Siare Engineering, the country's largest respirator manufacturer, to increase its monthly production capacity from 160 to 500 respirators.

It is understood that Italy currently has 3,000 ventilators, but this seems far from enough. Reuters reported on Saturday that the number of ventilators in Italy could only meet less than a quarter of the demand.

So Italy purchased 1,000 ventilators and 2 million masks, including epidemic prevention materials, from China.

In addition, according to some respirator manufacturers in Europe and the United States, in the short term, they can not speed up production, and the soaring demand is challenging to be met.

China's horsepower is in full swing to "build" respirators

"All Chinese ventilator manufacturers have reached their capacity limits and are all busy responding to foreign demand," said Wu Chuanpu, director of the supply chain for Chinese medical device e-commerce platform Belden Medical.

According to Wu, these manufacturers have orders that will allow them to run at total capacity until May. Biden Medical still receives about 60 to 70 new orders a day, each seeking hundreds or even thousands of these machines, with most of the orders coming from abroad, he said.

"Unlike medical supplies such as masks and thermometers, which can ramp up quickly, the production of ventilators has a high threshold, making it more difficult to expand production quickly." Wu Chuanpu added.

Even though ventilator expansion is complex, countries still spend a lot of money to accelerate the development or even cross-border manufacturing of ventilators. "For patients with new coronary pneumonia, ventilators are life-saving machines!" A doctor said. "A ventilator, you can extend the treatment time of a patient, especially for pneumonia patients with severe disease."

In this case, it is understandable that car manufacturers are forced to build respirators across borders. Tesla CEO Musk had said on March 19: "If there is a shortage of respirator supply, we (Tesla) can make it." As it turned out, it didn't take long for Musk to purchase 1,255 ventilators from China and has arranged to have them flown to Los Angeles, USA.

As you can see, the short-term transition to ventilators is not easy. The ventilators produced in China are now being rushed to Italy and other countries with severe epidemics overseas. And nearly 1,000 ventilators have been produced and delivered to the international market.

It has several thousand more ventilators being scheduled for emergency production. Anxin Securities said, "In the long run, China's medical equipment companies can further enhance their international influence, which is beneficial to the subsequent promotion of overseas products and channel layout."

Niki Lu (ph), an analyst at Bloomberg Information Research, also pointed out that China can supply at least 14,000 non-invasive ventilators in April, based on manufacturers' supply of ventilators to Wuhan, Hubei in March.

Who are the domestic ventilator manufacturers?

As the global trend of new coronary pneumonia spreads, ventilators with a high production threshold will face an oversupply trend in the short term. And with the gradual slowdown of the epidemic in China, the main supply of domestic ventilator brand manufacturers will shift to foreign markets. In the future, which brands will become the mainstay of the global ventilator market in the short term? Next, let's take a look.

Philips Wellcome

Wellcome is part of Philips. Formerly known as Wellcome Corporation, it was founded in 1976 and is headquartered in Pittsburgh, Pennsylvania, USA. In December 2007, the company was acquired by Philips, a Dutch company, to form the Philips Home Healthcare Division, which became Philips Wellcome. Philips Wellcome now has direct offices in Germany, France, the U.K., Italy, Switzerland, Japan, and China.

ResMed

Australia (ResMed) ResMed's respiratory company business mainly focuses on diagnosing and treating patients with sleep apnea products. The world's first sleep apnea machine inventor Professor Sullivan (dr. colin Sulivan), is one of the earliest founders of the company. ResMed has over 400 technical patents and more than 100 design patents and is a member of a global medical advisory board of sleep medicine authorities.

Ltd. was established in April 2007 as a direct branch of ResMed in China, with offices in Shanghai, Guangzhou, and Chengdu in addition to Beijing.

MAQUET MAQUET

MAQUET is one of the world's largest medical engineering and equipment suppliers for operating rooms and ICUs and is part of the medical systems group of the Swedish company GETINGE. The headquarters are in Rastatt on the edge of the pristine Black Forest in Germany. Under the Surgical Systems Division, Cardiac Surgery Division, and Critical Care Systems Division, the brands under its jurisdiction are all industry leaders, formerly MAQUET, ALM, HANAU, JOSTRA, SIEMENS (respiratory, anesthesia), etc.

Ltd. is a wholly owned subsidiary of MAQUET in China, providing the highest quality system engineering and products for operating rooms, cardiothoracic surgery, and ICUs in Chinese hospitals.

Fisher & Paykel

Fisher & Paykel Healthcare (Guangzhou) Co., Ltd. is a healthcare device company whose main products are respiratory humidification products, respiratory therapy support systems, and sleep apnea treatment products.

Delgado Medical

Dräger Meditec is one of the world's leading manufacturers of medical devices. It is the largest subsidiary of the Dräger Group (founded in 1889) and is a joint venture between the Dräger Group and the Siemens Group in a ratio of 65:35. 

It can provide products, integrated systems, and services in various therapeutic areas and throughout the patient care process, including emergency, operating room/anesthesia, critical care, perinatal care, and home care. Dräger Meditec is headquartered in Lübeck, Germany, and has R&D and production sites in Lübeck, Germany; Best, The Netherlands; Telford, Pennsylvania, USA; Danvers, Massachusetts, USA; and Shanghai, China.

Weinmann

Founded in 1874 and headquartered in Hamburg, Germany's economic and trade center, Weinmann Medical is a well-known German company with a history of more than 140 years and manufactured the first non-invasive ventilation device in Europe.

140 years, Weinmann Medical has been committed to the development of sleep diagnosis, sleep For more than 140 years, Wanman Medical has been committed to providing physicians. And patients with the highest quality medical devices and system solutions in the critical medical fields of sleep diagnosis, sleep therapy, ventilation therapy, and patient masks.

GE Medical

G.E. Healthcare started its business in China in 1979 and established its first office in Beijing in 1986. 1991 saw the establishment of AirHealth General Electric Medical Systems Ltd. in Beijing, which became G.E.'s first joint venture in China. Today, G.E. Healthcare has established several operating entities in China, including wholly owned and joint ventures, and has seven global manufacturing sites in China.

Xinsong Medical SYSMED Xinsong Ventilator

Ltd. is jointly researched and established by the Shenyang Institute of Automation and the Dalian Institute of Chemical Industry Physics and has long focused on researching, developing, and manufacturing oxygen therapy and respiratory therapy equipment. Xiong Medical has more than ten years of successful experience in product development, large-scale production, high-standard quality management, and cooperation with clinical experts. The State Key Laboratory of Robotics has accumulated profound technology in micro-robots, medical robots, network "teleoperated" robots, and human-machine fusion.

The development team of the Xinsong ventilator is jointly composed of Xinsong Medical and Shenyang Institute of Automation, Chinese Academy of Sciences. It has successfully developed a dual-level non-invasive ventilator by perfectly combining intelligent and adaptive control technology, signal analysis and medical sensing, clinical requirements, and respiratory physiology.

resmart

(BMC) was established in 2001 and has become a leader in respiratory products and services for China. Adhering to the corporate motto of "Care to the Family," BMC is committed to "providing high-quality products, professional services, and active care to help families around the world to cope with respiratory diseases" as its mission. And is committed to "becoming the preferred platform for global respiratory health management." BMC's mission is to provide high-quality products and professional services to help global families cope with respiratory diseases.

Headquartered in Beijing, BMC is a national and high-tech enterprise in Zhongguancun. As a leading enterprise in the same industry in China, BMC provides global users with diagnosis and treatment equipment for sleep and breathing disorders and related diseases and respiratory chronic disease management solutions through independent innovation. Its main products include three significant developments: sleep monitors, non-invasive ventilators, masks, and the BMC+ respiratory health management cloud platform.